Search
Showing results for "Neuromuscular disorders "
Previous studies of pulmonary diffusing capacity in children differed greatly in methodologies; numbers of subjects evaluated, and were performed prior to...
We compared the ability of Ars, to standard oscillatory outcomes, to determine respiratory disease and differentiate responses to inhaled bronchial challenges.
Better understanding of evolution of lung function in infants with cystic fibrosis...
Exhaled breath temperature (EBT) has been proposed for the non-invasive assessment of airway inflammation
Advances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.
Sensitive and reliable tests are required to monitor lung disease severity in cystic fibrosis.
While individual diseases are rare, as a group, rare diseases are common. Recent estimates suggest that between 3% and 6% of the world’s population are affected by rare disease.
One way the Wal-yan Respiratory Research Centre provides the opportunity for consumers and community members to contribute to our research is through participation in one of our eight community reference groups.
Mackenzie Crane was 10 months old when her parents, Jodie and Scott, were given the life-changing news that their daughter would never walk.
The aim of this review is to highlight the risk factors that may contribute to increased susceptibility to viral respiratory infections among preterm infants